Infantile malignant osteopetrosis (IMO) is a rare and lethal disease characterized by an absence of bone resorption due to inactive OCLs. Affected patients display an increased bone mass and hematological defects. The osteopetrotic oc/oc mouse displays a bone phenotype similar to the one observed in IMO patients, and the same gene, Tcirg1, is mutated in this model and in the majority of these patients. Therefore, we explored in oc/oc mice the consequences of the perturbed bone microenvironment on hematopoiesis. We show that the myelomonocytic differentiation is increased, leading to an elevated number of OCLs and dendritic cells. B lymphopoiesis is blocked at the pro-B stage in the bone marrow of oc/oc mouse, leading to a low mature B-cell number. T-cell activation is also affected, with a reduction of IFNc secretion by splenic CD4 þ T cells. These alterations are associated with a low IL-7 expression in bone marrow. All these data indicate that the lack of bone resorption in oc/oc mice has important consequences in both myelopoiesis and lymphopoiesis, leading to a form of immunodeficiency. The oc/oc mouse is therefore an appropriate model to understand the hematological defects described in IMO patients, and to derive new therapeutic strategies.
Introduction
Bone marrow is the main location of hematopoiesis in adult and interactions between bone and hematopoietic cells are essential to the normal development of both systems. Perturbations in the balance between the bone matrix formation by osteoblasts, and its resorption by osteoclasts (OCLs), lead to pathologies such as osteopetrosis, characterized by a defect in bone resorption. In human, osteopetrosis corresponds to various diseases classified on the basis of severity and age of onset, 1 among which, infantile malignant osteopetrosis (IMO) is the most severe form. This rare disorder has an incidence of about 1/200.000 and a high mortality rate in the first 2 years of life. 2 Affected patients display growth retardation, increased bone mass and failure of tooth eruption. IMO is also associated with immunological defects probably due to the failure of bone marrow development. Patients are anemic, present an extramedullary hematopoiesis and many become transfusion dependent. While recurrent infections are a major cause of death, the contribution of this phenomenon remains poorly characterized (for a review, see Wilson and Vellodi 2 ).
Several genetically modified or spontaneous osteopetrotic mutant mice have been described, in which OCLs are either absent or nonfunctional. 3 These models have largely contributed to the comprehension of the OCL differentiation and activity. However, only three models, the oc/oc, Clcn7
À/À and gl/gl mice, bare a mutation in genes that have also been involved in the human IMO and are thus potential candidates to study the physiopathology of the most severe form of human osteopetrosis.
In these three models, OCLs are present but ineffective in bone resorption. As a result, the mutant mice have a lifespan under 3 weeks and are growth retarded, the cortical region of long bones is thickened and the medullary cavity is severely reduced. The oc and the gl mutations are autosomal recessive mutations that appeared spontaneously. The oc mutation consists of a 1.6 kb deletion in the Tcirg1 (T-cell immune regulator 1) gene encoding the a3 subunit of the vacuolar proton pump (V-ATPase). 4 The V-ATPase is a protein complex addressed to the ruffled border when OCLs are actively resorbing the bone matrix. It mediates H þ transport into the resorption lacunae where a low pH is necessary for bone resorption. In the oc/oc mouse, the V-ATPase is present on endosomal vesicles of the OCLs, but is absent at the cell surface in contact with the bone matrix. 5 Consequently, OCLs are unable to acidify the resorption lacunae and to resorb bone. The gl mutation consists of a 7.5 kb deletion in the Gl gene encoding a cytoplasmic protein, whose role in OCL is still not clearly established. 6 The Clcn7 À/À mouse displays a disruption of the gene encoding the ClC-7 chloride channel, providing a Cl À conductive pathway that acts in concert with the V-ATPase in electroneutral hydrochloric acid transport during bone resorption. 7 Analysis of the litterature shows that few mutations in the CLCN7 gene [7] [8] [9] or in the GL gene 6 are associated with IMO, while the vast majority of the patients present mutations in the TCIRG1 gene. [10] [11] [12] [13] Therefore, the oc/oc mouse appears to be the most closely resembling model to investigate the physiopathology of the most severe form of human osteopetrosis.
In this paper, we have analyzed the hematological and immunological status of the oc/oc mouse in order to better understand the immunological defects associated with IMO. We report that hematopoiesis is altered in the oc/oc mouse. The myelomonocytic differentiation is increased in the bone marrow, the liver and the spleen. In contrast, the B-lymphoid differentiation is blocked at the pro-B to pre-B transition in the bone marrow. Furthermore, the secretion of IFNg by activated splenic CD4 þ T cells is dramatically reduced in the oc/oc mice. Altogether, our results suggest that the major perturbations of the bone architecture observed in the oc/oc mouse lead to alterations in hematopoiesis and have immunological consequences that may explain the high susceptibility for infections reported in patients affected with IMO.
Material and methods

Mice
Heterozygous (C57BL/6J Â C3HheB/FeJ) þ /oc mice were maintained in our animal facility in accordance with the general guidelines edicted by the Direction des Services Veterinaires. All analyses were performed on 17-day-old oc/oc and normal littermates. Mice were genotyped by a PCR test using three primers allowing the detection of the 1.6 kbp deletion present in the oc mutant allele 4: 5 0 -CCCTTCTCTGCCTTTCACC-3 0 , 5 0 -CTGCTTACAATTTGGGGAGG-3 0 and 5 0 -CAAGTGGGGA-CACACATCG-3 0 .
Cell preparation
Bone marrow cells from normal mice were collected by flushing femoral shafts, and those from oc/oc mice by crushing the femora and vigorous pipetting. Splenocytes were isolated by filtration through a 40 mm cell strainer (Becton-Dickinson), followed by red blood cell depletion (Red Blood Cell Lysis, Sigma). Liver was perfused in situ with a 0.1 mg/ml collagenase-D solution, followed by further ex vivo digestion with 1 mg/ml collagenase-D (Roche, Meylan, France) in aMEM medium (Invitrogen) for 30 min at 371C under shaking. After filtration through a 40 mm cell strainer, hematopoietic cells were isolated from this population by centrifugation on a 40-70% Percoll gradient (Invitrogen, Cergy-Pontoise, France) at 600 g for 25 min.
Clonogenic assays in semisolid medium
Myeloid progenitors were assayed in triplicate in 0.5 ml of methylcellulose culture medium containing IL-3, IL-6, SCF and Epo (Methocult M3434; Stem Cell Technologies, Meylan, France). Spleen cells (2.5 Â 10 4 cells in 0.5 ml) and liver cells (6 Â 10 3 cells in 0.5 ml) were cultured under these conditions at 371C in 5% CO 2 for 7-12 days. The pre-B colony-forming units were assayed by culturing 2.5 Â 10 4 spleen or liver cells in methylcellulose culture medium supplemented with recombinant human IL-7 (Methocult 3630; Stem Cell Technologies) as described.
14 Triplicates of each sample were seeded and incubated at 371C in 5% CO 2 for 7 days. Myeloid and pre-B CFU cells were scored under optical microscopy.
Flow cytometry analysis
Single-cell suspensions were incubated with Fc block t CD16/ 32 (2.4G2) and stained with FITC-, PE-or Cy-chrome antibodies reactive to CD11b (M1/70), CD43 (S7), B220 (RA3-6B2), CD11c (HL3), CD8 (53-6.7), CD4 (L3T4) (all from Becton-Dickinson) and CTR (calcitonin receptor). 15 All staining steps were performed at 41C in PBS with 0.1% BSA and 0.02 mM NaN 3 . After washes, the labeled cells were analyzed on a FACScan (Becton-Dickinson).
Cytokine assays
Sandwich ELISAs were used to measure IL-4 and IFNg with anti-IL-4 (11B11) or anti-IFNg (XGM1.2) Abs (Beckton Dickinson) on supernatants from purified splenocytes CD4
þ T cells, stimulated in vitro for 48 h with coated anti-CD3 (145-2C11) and soluble anti-CD28 (37.51). After overnight incubation at 41C, the second-step biotin antibodies (BVD6-24G2 and R4-6A2 for IL-4 and IFNg, respectively) were added. After 1 h incubation at room temperature, avidin-horseradish peroxidase enzyme was added to each well. Plates were incubated at room temperature for 1 h, washed and 100 ml/well of substrate (TMB-Elisa, Invitrogen) was added. The plates were then read on an ELISA reader (Dynex).
Immunohistochemistry
Femora were fixed in 4% paraformaldehyde for 24 h at 41C and decalcified for 10 days in 10% EDTA at 41C. They were then incubated overnight in a 30% sucrose solution and 10 mm sections were obtained with a cryotome (ThermoShandon, Pittsburgh, USA). Bone sections were stained for TRAP activity with the leukocyte acid phosphatase kit (Sigma) and observed by light microscopy (CarlZeiss, France).
Real-time PCR analysis
Total RNA from bone marrow was extracted by adsorption onto silica membranes (Macherey-Nagel, Dü ren, Germany). Total RNA (1 mg) was reverse transcribed with random primers according to the manufacturer's protocol (Invitrogen). Real-time PCR analysis were performed on an ABI Prism 7000 (Applied Biosystems), in a 20 ml volume containing 10-fold diluted cDNA, 10 ml SYBR Green Master Mix and 300 nM of each primer. Samples were treated according to the following program: 501C for 2 min, 941C for 10 min and 40 cycles of 951C for 15 s and 601C for 1 min. Analyses were carried out in triplicate on samples derived from two oc/oc and two control littermates. For each sample, the cycle threshold (C t ) values were determined. Test cDNA results were normalized to 18S RNA on the same plate. Differences in gene expression between oc/oc and control mice were calculated using the 2 ÀDCt method. 16 At the end of the PCR assay, the specificity of amplification was controlled by generating a melting curve of the PCR product and analysis by gel electrophoresis. The primers used were: 
In vitro osteoclast differentiation
Cells isolated from the liver and spleen were plated in a collagen-coated 24-well plate at 1.5 Â 10 5 cells/well in aMEM medium supplemented with 5% fetal calf serum (Hyclone, Perbio, Bezons, France), 25 ng/ml mouse recombinant M-CSF and 30 ng/ml mouse RANK-L (R&D Systems, Lille, France). After 3-week cultures, cells were fixed in a 2% glutaraldehyde solution and stained for TRAP activity with the leucocyte acid phosphatase kit (SIGMA). OCL differentiation was evaluated by the presence of multinucleated TRAP þ cells.
Results
Altered intramedullary hematopoiesis in oc/oc mouse
Homozygous mutant oc/oc mice display severe osteopetrosis and die within 3 weeks after birth, whereas no abnormal phenotype has been observed in heterozygous þ /oc mice. All molecular and cellular parameters studied so far have been identical in þ / þ and þ /oc mice. The bone marrow cellularity is dramatically decreased in oc/oc mice compared to normal mice ( Figure 1) . We characterized the B-cell subpopulations present in the remaining bone marrow cells of oc/oc mice by flow cytometry using antibodies against B220 and CD43. 17 The percentage of B220 þ CD43 þ pro-B cells was dramatically increased, whereas the percentage of B220 low CD43 À pre-and immature B cells and B220 high CD43 À mature B cells was decreased in oc/oc mice compared to normal littermates ( Figure 1a) . Thus, the progression from pro-B to pre-B cells is blocked in the bone marrow of oc/oc mice.
The myelomonocytic lineage and pre-OCLs were also analyzed in the bone marrow. OCLs are derived from the CD11b þ myeloid lineage and express the calcitonin receptor (CTR) from the pre-OCL to the differentiated OCL stages. 15 An augmented percentage of the myeloid CD11b þ population was observed in the oc/oc mice mostly in the CD11b þ CTR þ cells, including the pre-OCL population (Figure 1b) . These data indicate a global increase of the myelomonocytic differentiation in the oc/oc bone marrow.
Alterations in the bone marrow hematopoietic cells are frequently associated with extramedullary hematopoiesis. Therefore, in oc/oc mice, we have analyzed the hematological status in the liver and in the spleen, which are the main locations of hematopoiesis in the mouse fetal and perinatal life, respectively.
Impaired B lymphopoiesis in oc/oc mice
Spleen cellularity was decreased in oc/oc mice, whereas no significant differences were observed in the liver (Figure 2 ). The percentage of B220 þ cells was reduced by two-fold in the liver and by five-fold in the spleen of oc/oc mice, and this decrease affected mostly the B220 low CD43 À pre-and immature B cells (Figure 2a, b) . In both organs, no difference was observed in the percentage of B220 þ CD43 þ pro-B cells. These results were confirmed by clonogenic assays, revealing that the number of pre-B colony-forming cells was significantly lower in oc/oc mice compared to normal littermates both in the spleen and in the liver (Figure 2c) . Together, these results indicate that B lymphopoiesis is decreased in the spleen and to a lesser extent in the liver of oc/oc mice.
Altered T-lymphopoiesis in oc/oc mice
The thymic cellularity ( Figure 3 ) and size (data not shown) were decreased in oc/oc mice. The percentage of double-positive (DP) CD4 þ CD8 þ was reduced in the thymus of oc/oc mice, whereas the percentage of single-positive (SP) CD8 þ and CD4 þ cells was increased (Figure 3a, b) . However, in the spleen (Figure 3a, b) and in the liver (data not shown), no significant difference was observed in the T-cell subpopulations between normal and mutant mice. 
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The function of the splenic CD4 þ T-cells was assessed by ELISA through the secretion analysis of IFNg (Th1 response) and IL-4 (Th2 response), after stimulation with coated anti-CD3 and soluble anti-CD28 antibodies. In each condition, the proliferation was equivalent for cells issued from mutant or control mice (data not shown). However, a dramatic decrease in INFg secretion was observed in cells from the mutant mice (Figure 3c) . No IL-4 secretion was detected in T cells derived from normal or oc/oc mice (data not shown). Thus, the activation of splenic T-cells from oc/oc mice was markedly impaired compared to normal mice.
Increased myelopoiesis in oc/oc mice
The myelomonocytic lineage was analyzed in the liver and spleen of oc/oc and normal mice by flow cytometry. An increased percentage of myeloid CD11b þ cells (Figure 4a , b) and an increased number of myeloid progenitors (Figure 4d) were observed in the oc/oc mice in both organs. The dendritic CD11b þ CD11c low population 18 was dramatically increased in oc/oc mice compared to normal littermates (Figure 4a ). Moreover, the CD11b þ CTR þ population including preOCLs was also markedly increased, both in the liver and in the spleen (Figure 4b, c) . The osteoclastogenic differentiation capacity of cells issued from the bone marrow, spleen and liver of mutant and normal mice was analyzed in vitro in the presence of RANK-L and M-CSF. Differentiated OCLs were defined as multinucleated cells (at least three nuclei) expressing the OCL marker TRAP (tartrate-resistant acid phosphatase). For each organ, the number of multinucleated TRAP þ cells derived from oc/oc mice was 5-6-fold higher with cells from oc/oc mice (Figure 4e ). This result is consistent with the high number of preOCLs observed in the oc/oc mice. Altogether, these data indicate a global increase in the myeloid differentiation and an extramedullary myelopoiesis in the oc/oc mice. Hematological defects in the oc/oc mouse C Blin-Wakkach et al
Low expression of IL-7 in the bone marrow of oc/oc mice
The alterations in hematopoietic populations observed in oc/oc mice could result from a compromised environment in the bone marrow. Indeed, histological analysis of the bone showed that bone architecture was dramatically altered and that the marrow space of oc/oc mice was filled with disorganized and numerous bone trabeculae (Figure 5a-d) . Staining for TRAP activity showed an increased number of inactive OCLs in contact with the trabecular bone surface of oc/oc mice, when compared to normal littermates (Figure 5c and d) . In this altered microenvironment, we analyzed the expression of IL-7, a stromal factor essential for T and B lymphopoiesis and described as an inhibitor of osteoclastogenesis. 19 Real-time RT-PCR analysis revealed that IL-7 m-RNA expression in the bone marrow displays a 3-5-fold reduction in the mutant mice (Figure 5e ). These results strongly suggest that the alterations in B-and T-cell populations could be due to the low IL-7 gene expression by bone marrow stromal cells. This low IL-7 expression might be the consequence of either a reduction in the stromal cell number or an interaction defect between stromal and hematopoietic cells related to the bone microarchitecture disorganization.
Discussion
Increased myelomonocytic and osteoclastic differentiation in oc/oc mice The oc/oc mouse is an original model among the murine osteopetrotic models due to its phenotype being very similar to that of IMO patients. Furthermore, the oc mutation affects theTcirg1 gene, which is the most frequently altered gene in human IMO. [10] [11] [12] [13] Therefore, the oc/oc mouse represents a suitable animal model for studying the hematological defects observed in IMO patients.
In this model, the high percentage of myeloid CD11b þ cells and the increased number of myeloid progenitors reveal an augmented intra-and extramedullary myelopoiesis. We also observed a general increase of osteoclastogenesis in oc/oc mice. In this regard, an increased number of inactive OCLs has also been observed in the mi/mi and c-Src À/À osteopetrotic mice, 20, 21 and an elevation in the number of myeloid cells has been reported in the rank À/À , opgl À/À and NFkB À-/À mice. [22] [23] [24] Therefore, the upregulation in the myelomonocytic differentiation may represent a general feedback mechanism related to the absence of bone resorption by OCLs. Interestingly, a similar increase in the number of OCLs has been observed in IMO patients, 25 which strongly suggests that this regulatory mechanism may also exist in human osteopetrosis.
Impaired B lymphopiesis in oc/oc mice B lymphopoiesis is also affected in oc/oc mice. In the bone marrow, the increased B220 þ CD43 þ pro-B population and the reduced B220 low CD43 À pre-B and B220 high CD43 À mature Blymphocyte subpopulations reveal that the progression from pro-B to pre-B cells is blocked. However, the pro-B cells are still capable of differentiating into immature B cells in vitro (data not shown) and mature B cells are present in the liver of mutant mice. Thus, the block in B-cell differentiation is not due to a cell autonomous effect of the oc mutation within the B lineage, but is rather the consequence of the altered bone marrow architecture.
Interestingly, in all the osteopetrotic models where the B lymphopoiesis has been studied, a dramatic reduction in mature B-cell number has been reported. [22] [23] [24] [26] [27] [28] In the bone marrow, B-cell progenitors are immediately adjacent to the bone surface and this spatial organization is essential for B lymphopoiesis. 29, 30 Thus, the perturbations observed in the bone marrow microenvironment of osteopetrotic mice are probably responsible for the impaired B lymphopoiesis.
IL-7 is a stromal-derived lymphoid-specific cytokine necessary for the pro-B to pre-B cell transition. 31 IL-7 secretion requires a contact between stromal cells and B-cell precursors. 32, 33 The reduced IL-7 mRNA level observed in oc/oc bone marrow could therefore be a consequence of either a reduction in the stromal cell number, or a consequence of altered interactions between stromal and hematopoietic cells due to the severe perturbations of bone architecture. Expression of IL-7 in the bone marrow has also been analyzed in the osteopetrotic mi/mi mouse and was found relatively equivalent in the mi/mi and control mice. 27 Despite the fact that these two models of osteopetrosis are not equivalent, this apparent discrepancy with our results may be explained by the higher sensitivity of realtime RT-PCR used in our study compared with semiquantitative RT-PCR used for the mi/mi mice.
The perturbations of bone and stromal environment in the oc/ oc mice are likely to be critical factors leading to the low level of IL-7 expression and consequently to the decrease in the number of pre-B, immature and mature B cells. Furthermore, Lee et al 19 have recently reported that IL-7 is also a negative regulator of osteoclastogenesis. Consequently, the low level of IL-7 mRNA observed in the oc/oc mouse would also contribute to the increased osteoclastogenesis.
Altered immunological status in oc/oc mice
The thymic size and cellularity as well as the percentage of thymic CD4 þ CD8 þ DP cells are reduced in oc/oc mice. Since thymic T-cell progenitors are issued from fetal liver or bone marrow, 34 our results could reflect a defection in the number of these precursors and/or in their homing from the bone marrow Hematological defects in the oc/oc mouse C Blin-Wakkach et al to the thymus, due to the perturbed oc/oc bone architecture and due to the low level of IL-7 expression in the bone marrow. The increased percentage of thymic SP CD4 þ and CD8 þ T cells in oc/oc mice is likely a consequence of the relative decrease in DP cells or, alternatively, could indicate that the thymic positive selection is affected in these animals. However, such an increase in SP cells has not been observed in IL-7 À/À mice. 31 This difference could be explained by the fact that in oc/oc mice IL-7 expression is decreased but not null, and that IL-7 is probably not the only stromal factor whose expression is modified. Interestingly, the secretion of INFg by activated splenic CD4 þ T-cells from oc/oc mice is decreased. INFg has been reported to inhibit osteoclastogenesis. 35 Thus, the low INFg secretion may participate in the increased osteoclastogenesis. A similar decrease has been reported in the osteopetrotic opgl À/À mouse, in which T-cell development is altered. 23 Since the addition of OPGL did not restore it, this decrease was attributed to the perturbed T-cell development rather than to a lack of OPGL. In the same manner, the impaired INFg secretion observed in oc/oc mouse could be due to the alteration of T-cell precursor populations. Alternatively, it could also result from a direct effect of the oc mutation. Indeed, whereas up to now, a role for the vacuolar proton pump a3 subunit in T cells has not been reported, the Tcirg1 gene encodes for another protein, TIRC7 (T-cell immune response cDNA-7) involved in T cell activation. 36 In the oc/oc mouse, the sequence encoding the TIRC7 protein is not affected by the oc mutation and TIRC7 is expressed in T lymphocytes (data not shown). However, a role of the a3 subunit in the secretion of INFg cannot be excluded. Furthermore, as in IMO patients, some of the mutations reported in the TCIRG1 gene affect both a3 and TIRC7, a systematic analysis of the correlation between the genotype and the T-cell activation phenotype of the patients remains to be explored.
In oc/oc mice, we have shown that the splenic CD11b þ CD11c low dendritic population is increased. Recently, this CD11b
þ CD11c low population has been shown to be a tolerogenic population secreting IL-10. 18 Thus, accumulation of these cells in the spleen, together with the low secretion of INFg by T cells and the reduced mature B-cell number, would probably lead to a nonresponsive status to microbial agents. Such alterations of the immune response could probably participate in the high susceptibility to infections described in IMO patients. 2 In conclusion, the bone microenvironment perturbations induced by the loss of OCL activity in the oc/oc mouse affect lympho-and myelopoiesis, probably through the action of signals originating from the bone microenvironment itself, such as the expression of Il-7 by stromal cells. We can hypothesize that these signals are developed to increase the OCL number in order to compensate their loss of function. Furthermore, these alterations in lympho-and myelopoiesis lead to a decrease in mature B-cell number, an increase in the CD11b þ CD11c low dendritic population and an impaired secretion of IFNg by T cells. Consequently, this altered immunological status could qualify the oc/oc mouse as immunodeficient.
To date, the only cure for IMO patients has been bone marrow transplantation, but the efficiency of this treatment depends on the availability of a HLA-compatible donor and must be done as early as possible. 37 Immunological defects equivalent to those we describe in the oc/oc mice would explain the high susceptibility to infections displayed by IMO patients. Therefore, a systematic analysis of the immunological status of IMO patients could provide new insights into the potential use of immunotherapy in order to improve their survival prior to bone marrow transplantation.
